Piramal Enterprises gets grant for pharmaceutical kit for cancer treatment with CDK and antioxidant

Discover the groundbreaking patent by Piramal Enterprises Ltd for a pharmaceutical kit combining CDK and antioxidant enzyme inhibitors to revolutionize cancer treatment. Learn more about this innovative therapy now!

Related Posts

Transgene’s stock drops after Phase II cancer jab trial...

Oct 16, 2024

JAMA’s new editor settles in, bringing open access and ...

Mar 19, 2023

STAT+: 3 CRISPR advances to watch in 2024

Dec 27, 2023